Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06294678 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Nov 30, 2025 to Sep 30, 2025
    • Site details revised at 6 of 6 sites
    v4
  2. Primary endpoint revised
    • Secondary endpoints revised (9)
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 6
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To observe the effect of stem cell infusion on the development of acute graft-versus-host disease (aGVHD) in patients with malignant hematologic diseases after allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT)
Trial Details
NCT Number NCT06294678
Lead Sponsor Anhui Provincial Hospital
Conditions
(from sponsor)		 Acute Graft-versus-host Disease
Enrollment 198 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov